在線研究市場再添Blockchain驗證服務

USI科技改變你的生活與最簡單的和最被動的比特幣投資

Scientist.com, 外包研究一個在線市場, has launched a blockchain-based data verification platform, the company announced on Monday.

Dubbed DataSmart, the platform will allow biotechnology and pharmaceutical companies to demonstrate the veracity of electronically submitted research data to regulatorsspecifically that which companies obtain during the preclinical and clinical stages of drug development.

In biopharma research we need blockchain technology to verify and validate the supply chain and to ensure the integrity of research data,” Chris Petersen, Scientist.com’s CTO and founder said in a statement, 加入:

Our new DataSmart platform enables pharmaceutical and biotech companies to demonstrate that critical supplier information and important research data has not been tampered with and remains unaltered.

The company said the service will specifically help biopharmaceutical firms comply with 21CFR Part 11, a regulation that outlines the standards electronic records must meet in order for the U.S. Food and Drug Administration to consider them reliable and equivalent to paper records.

The cost and time spent adhering to 21CFR Part 11 has made it prohibitive to ensure data integrity at earlier stages of the drug discovery and development process,” Scientist.com CEO and founder Kevin Lustig said in the statement.

Big pharma firms Pfizer, Amgen and Sanofi also started exploring blockchain applications to the industry in January. The companies are specifically pursuing use cases related to data management and movement and patient communication automation among others.

Pills 圖片 通過存在Shutterstock

在blockchain新聞領導者, CoinDesk是爭取最高的新聞標準,並通過遵守媒體插座 嚴格的一套編輯政策. CoinDesk是數字貨幣集團的獨立運營子公司, 投資於cryptocurrencies和blockchain新創.

HTTPS://www.coindesk.com/online-research-marketplace-adds-blockchain-verification-service/

USI技術最簡單的被動投資比特幣

發表評論